scispace - formally typeset
S

Shizhu Chen

Researcher at Chinese Academy of Sciences

Publications -  46
Citations -  2939

Shizhu Chen is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Drug delivery & Drug carrier. The author has an hindex of 22, co-authored 45 publications receiving 1778 citations. Previous affiliations of Shizhu Chen include Center for Excellence in Education & Hebei University.

Papers
More filters
Journal ArticleDOI

Comprehensive understanding of magnetic hyperthermia for improving antitumor therapeutic efficacy.

TL;DR: A comprehensive understanding of MH for improving antitumor therapeutic efficacy is provided, which would be of utmost benefit towards guiding the users and for the future development of MNPs-MH towards successful application in medicine.
Journal ArticleDOI

Self-Supply of O 2 and H 2 O 2 by a Nanocatalytic Medicine to Enhance Combined Chemo/Chemodynamic Therapy.

TL;DR: The construction of a nanocatalytic medicine, CaO2@DOX@ZIF‐67, via a bottom‐up approach, that simultaneously supplies O2 and H2O2 to achieve improved chemo/chemodynamic therapy.
Journal ArticleDOI

Near-Infrared Emission CuInS/ZnS Quantum Dots: All-in-One Theranostic Nanomedicines with Intrinsic Fluorescence/Photoacoustic Imaging for Tumor Phototherapy

TL;DR: The use of CuInS/ZnS quantum dots (ZCIS QDs) as "all-in-one" versatile nanomedicines that possess intrinsic imaging and therapeutic capabilities within a well-defined nanostructure allow high therapeutic efficacy as well as noninvasively monitoring tumor site localization profiles by imaging techniques and thus hold great potential as precision theranostic nanomedICines.
Journal ArticleDOI

Hybrid Mesoporous Silica-Based Drug Carrier Nanostructures with Improved Degradability by Hydroxyapatite

TL;DR: The biological experiment results show that the mesoporous silica nanoparticles/hydroxyapatite (MSNs/HAP) hybrid drug carrier not only exhibits good biocompatibility and antitumor effect but also greatly reduces the side effects of free DOX.